Table 3.
Survey responses, stratified by dichotomized score on Perceived Stress Scale (n = 203)
| Survey items |
Overall n = 203 |
Low stress n = 94 |
High stress n = 109 |
|---|---|---|---|
| Decreased or stopped NSAID | 29 (14%) |
8 (8%) |
19 (17%) |
| Decreased or stopped biologic | 20 (10%) | 9 (9%) |
11 (10%) |
| Decreased or stopped exercise |
116 (57%) |
47 (50%) |
69 (63%) |
| Job changed | 27 (13%) |
10 (10%) |
17 (16%) |
| Current work location |
Not working: 55 (27%) Home: 123 (61%) Hospital: 7 (3%) Restaurant: 2 (1%) Other: 16 (8%) |
Not working: 21 (22%) Home: 60 (64%) Hospital: 2 (2%) Restaurant: 1 (1%) Other: 10 (11%) |
Not working: 34 (31%) Home: 63 (58%) Hospital: 5 (5%) Restaurant: 1 (1%) Other: 6 (6%) |
| Tested for COVID‐19 | 9 (4 %) | 4 (4%) | 5 (5%) |
| BASDAI (0‐10) |
2.5 ± 1.9 1.8 (1.1‐3.4) |
1.9 ± 1.7 1.4 (0.8‐2.5) |
3 ± 2 2.3 (1.6‐3.9) |
| Perceived Stress Scale (0‐40) |
15 ± 8 14 (9‐20) |
8 ± 3 9 (6‐11) |
21 ± 5 20 (17‐24) |
| PROMIS Anxiety scale (39‐82) |
54 ± 9 54 (49‐61) |
49 ± 6 49 (46‐54) |
59 ± 8 61 (54‐65) |
| CES‐D scale (0‐60) |
14 ± 10 12 (6‐19) |
7 ± 5 6 (3‐10) |
20 ± 10 17 (12‐27) |
Continuous variables reported as mean ± SD and median (interquartile range); categorical variables reported as n (%)
Abbreviations: BASDAI, Bath Ankylosing Spondylitis Disease Activity Index; CES‐D, Center for Epidemiologic Studies Depression; COVID‐19, coronavirus disease 2019; NSAID, nonsteroidal anti‐inflammatory drug; PROMIS, Patient‐Reported Outcome Measurement Information System.